drugset / Trial / NCT02788747
Effect of Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Reduced Ejection Fraction
RandomizedParallel-groupTriple-blindTreatment
Summary
This was a randomized, double-blinded, placebo-controlled, multiple-dose study in subjects with stable heart failure (HF) with reduced ejection fraction (HFrEF).
Timeline
- Start
- 2016-06
- Primary completion
- 2017-09
- Completion
- 2017-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Elamipretide | Peptide | 4 mg | Subcutaneous |
| Subject | Elamipretide | Peptide | 40 mg | Subcutaneous |